These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37880853)

  • 21. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
    Zhao X; Cui L
    J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel six-microRNA-based model to improve prognosis prediction of breast cancer.
    Lai J; Wang H; Pan Z; Su F
    Aging (Albany NY); 2019 Jan; 11(2):649-662. PubMed ID: 30696800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening protective miRNAs and constructing novel lncRNAs/miRNAs/mRNAs networks and prognostic models for triple-negative breast cancer.
    Zhao Y; Song Y; Zhang Y; Ji M; Hou P; Sui F
    Mol Cell Probes; 2023 Dec; 72():101940. PubMed ID: 37871689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.
    Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise and weight loss interventions and miRNA expression in women with breast cancer.
    Adams BD; Arem H; Hubal MJ; Cartmel B; Li F; Harrigan M; Sanft T; Cheng CJ; Pusztai L; Irwin ML
    Breast Cancer Res Treat; 2018 Jul; 170(1):55-67. PubMed ID: 29511965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.
    Worakitchanon W; Panvongsa W; Siripoon T; Kitdumrongthum S; Wongpan A; Arsa L; Trachu N; Jinawath N; Chairoungdua A; Ngamphaiboon N
    JCO Precis Oncol; 2023 May; 7():e2300003. PubMed ID: 37163716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondria-related core genes and TF-miRNA-hub mrDEGs network in breast cancer.
    Yan LR; Wang A; Lv Z; Yuan Y; Xu Q
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
    Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
    J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 33. An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer.
    Jayasingam SD; Citartan M; Mat Zin AA; Rozhdestvensky TS; Tang TH; Ch'ng ES
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candidate miRNAs in human breast cancer biomarkers: a systematic review.
    Adhami M; Haghdoost AA; Sadeghi B; Malekpour Afshar R
    Breast Cancer; 2018 Mar; 25(2):198-205. PubMed ID: 29101635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
    Madhavan D; Peng C; Wallwiener M; Zucknick M; Nees J; Schott S; Rudolph A; Riethdorf S; Trumpp A; Pantel K; Sohn C; Chang-Claude J; Schneeweiss A; Burwinkel B
    Carcinogenesis; 2016 May; 37(5):461-70. PubMed ID: 26785733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
    Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
    BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
    Bitaraf A; Babashah S; Garshasbi M
    J Clin Lab Anal; 2020 Feb; 34(2):e23063. PubMed ID: 31595567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatic analysis and
    Li W; Kong X; Huang T; Shen L; Wu P; Chen QF
    Ann Transl Med; 2020 Nov; 8(21):1422. PubMed ID: 33313167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages.
    Sadeghi H; Kamal A; Ahmadi M; Najafi H; Sharifi Zarchi A; Haddad P; Shayestehpour B; Kamkar L; Salamati M; Geranpayeh L; Lashkari M; Totonchi M
    RNA Biol; 2021 Nov; 18(sup2):747-756. PubMed ID: 34793290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.